Skip to main content
Alligator Bioscience logo

Alligator Bioscience — Investor Relations & Filings

Ticker · ATORX ISIN · SE0024173637 LEI · 549300E15VI0MB7LXV19 ST Manufacturing
Open in API
Filings indexed 612 across all filing types
Latest filing 2017-03-31 Declaration of Voting R…
Country SE Sweden
Listing ST ATORX

About Alligator Bioscience

https://alligatorbioscience.se/en/

Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.

Recent filings

Filing Released Lang Actions
Ändring av antalet aktier och röster i Alligator Bioscience AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated March 31, 2017, announcing a change in the total number of shares and votes due to the exercise of stock options. This directly relates to a change in the company's capital structure (issuance of new shares). According to the definitions, 'Share Issue/Capital Change (Code: SHA)' covers announcements regarding new share issues or capital changes. Although it is a press release, the core subject matter is a capital change, making SHA a more specific fit than the general 'RPA' or 'RNS'. The document explicitly details the increase in shares from 575,000 exercised options.
2017-03-31 Swedish
Alligator announces completion of first phase I study with CD40 agonistic immuno-oncology antibody ADC-1013
Regulatory Filings Classification · 1% confidence The document is explicitly labeled as a "Press release" dated March 23, 2017. It announces the completion of the first phase I study for a drug candidate (ADC-1013) and provides details about the study, future plans (presenting results in Q4 2017), and contact information. This type of announcement, which communicates material, non-financial operational updates (like clinical trial milestones) to the market via a press release, typically falls under general regulatory announcements or investor relations communications. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change, the most appropriate general category for a material operational update disseminated via press release is Regulatory Filings (RNS), which serves as a broad category for such disclosures not covered by more specific codes. The document length is relatively short (4182 chars), suggesting it is an announcement rather than a comprehensive report.
2017-03-23 English
Alligator meddelar fullbordande av den första kliniska fas I-studien med den CD40-agonistiska immunonkologiska antikroppen ADC-1013
Regulatory Filings Classification · 1% confidence The document is a press release dated March 23, 2017, announcing the completion of the first Phase I clinical study for the drug candidate ADC-1013. It details the study's progress, future plans for data analysis and presentation, and mentions an associated webcast. This type of announcement, which communicates a specific operational or clinical milestone (completion of a study phase) and often includes details about future reporting or investor events, fits best under the general category of regulatory announcements or investor relations updates. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a formal dividend notice (DIV), and it is a specific operational update, it is classified as a general Regulatory Filing (RNS) as it serves as a mandatory public disclosure under market regulations (mentioned: EU's Market Abuse Regulation). It is too detailed to be just a Report Publication Announcement (RPA) which usually just announces the release of another document.
2017-03-23 Swedish
Annual Report 2016
Annual Report Classification · 1% confidence The document is titled 'Årsredovisning 2016' (Annual Report 2016) and contains a comprehensive table of contents covering business highlights, management review, corporate governance, and full financial statements (income statement, balance sheet, cash flow, notes, and audit report). Given the length and the inclusion of complete financial reporting for the fiscal year, it is classified as an Annual Report (10-K). FY 2016
2017-03-22 Swedish
Report Publication Announcement 2017
Report Publication Announcement Classification · 1% confidence The document is a press release dated March 22, 2017, explicitly stating that the 'Annual Report for 2016 now is available' on the company website. The document itself is very short (1714 characters) and serves only to announce the publication of the full Annual Report, rather than containing the full report content. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published classifies as a Report Publication Announcement (RPA).
2017-03-22 English
Notice of annual shareholders’ meeting in Alligator Bioscience AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of annual shareholders' meeting in Alligator Bioscience AB (publ)". It details the date, time, location, procedures for participation (including proxy rules), and the proposed agenda for the meeting. The agenda items cover the election of the Chairman, approval of financial statements (Annual Report/Audit Report), dividend resolution, election of the board/auditors, and remuneration policies. This content is characteristic of the official notice sent out to shareholders in advance of an Annual General Meeting (AGM). While it mentions the Annual Report and Audit Report, the document itself is the notice calling the meeting, not the reports themselves. Therefore, the most appropriate classification is AGM Information (AGM-R).
2017-03-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.